Anuv Ratan

Anuv Ratan serves as a Director at KKR & Co. Inc. since 2017 and holds multiple board positions in various companies including Immedica Pharma AB, Precipart, Biosynth, Dawn Biopharma, Sapphiros, and Gamma Biosciences, contributing expertise in areas such as rare diseases, precision components for medical devices, life sciences reagents, biopharma investments, consumer diagnostics, and bioprocessing tools. Additionally, Anuv Ratan acts as a board member and observer for clinical trial management at Headlands Research, and interventional medical devices at Cordis. Anuv Ratan's educational background includes a degree from Harvard University.